Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery and In Vivo Efficacy of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 4-(2-Aminoethyl)-N-(3,5-dimethylphenyl)piperidine-1-carboxamide Hydrochloride (AP163) for the Treatment of Psychotic Disorders.
Krasavin M, Peshkov AA, Lukin A, Komarova K, Vinogradova L, Smirnova D, Kanov EV, Kuvarzin SR, Murtazina RZ, Efimova EV, Gureev M, Onokhin K, Zakharov K, Gainetdinov RR. Krasavin M, et al. Among authors: zakharov k. Int J Mol Sci. 2022 Sep 30;23(19):11579. doi: 10.3390/ijms231911579. Int J Mol Sci. 2022. PMID: 36232878 Free PMC article.
Discovery of Trace Amine Associated Receptor 1 (TAAR1) Agonist 2-(5-(4'-Chloro-[1,1'-biphenyl]-4-yl)-4H-1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the Treatment of Psychotic Disorders.
Krasavin M, Lukin A, Sukhanov I, Gerasimov AS, Kuvarzin S, Efimova EV, Dorofeikova M, Nichugovskaya A, Matveev A, Onokhin K, Zakharov K, Gureev M, Gainetdinov RR. Krasavin M, et al. Among authors: zakharov k. Biomolecules. 2022 Nov 7;12(11):1650. doi: 10.3390/biom12111650. Biomolecules. 2022. PMID: 36359001 Free PMC article.
Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18-60 and 60+ Age Cohorts.
Gordeychuk IV, Kozlovskaya LI, Siniugina AA, Yagovkina NV, Kuzubov VI, Zakharov KA, Volok VP, Dodina MS, Gmyl LV, Korotina NA, Theodorovich RD, Ulitina YI, Vovk DI, Alikova MV, Kataeva AA, Kalenskaya AV, Solovjeva IV, Tivanova EV, Kondrasheva LY, Ploskireva AA, Akimkin VG, Subbotina KA, Ignatyev GM, Korduban AK, Shustova EY, Bayurova EO, Zhitkevich AS, Avdoshina DV, Piniaeva AN, Kovpak AA, Antonova LP, Rogova YV, Shishova AA, Ivin YY, Sotskova SE, Chernov KA, Ipatova EG, Korduban EA, Ishmukhametov AA. Gordeychuk IV, et al. Among authors: zakharov ka. Viruses. 2023 Aug 29;15(9):1828. doi: 10.3390/v15091828. Viruses. 2023. PMID: 37766235 Free PMC article. Clinical Trial.
Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF-α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients.
Lomakin Y, Belogurov A Jr, Glagoleva I, Stepanov A, Zakharov K, Okunola J, Smirnov I, Genkin D, Gabibov A. Lomakin Y, et al. Among authors: zakharov k. Mediators Inflamm. 2016;2016:2847232. doi: 10.1155/2016/2847232. Epub 2016 Apr 28. Mediators Inflamm. 2016. PMID: 27239100 Free PMC article. Clinical Trial.
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study.
Belogurov A Jr, Zakharov K, Lomakin Y, Surkov K, Avtushenko S, Kruglyakov P, Smirnov I, Makshakov G, Lockshin C, Gregoriadis G, Genkin D, Gabibov A, Evdoshenko E. Belogurov A Jr, et al. Among authors: zakharov k. Neurotherapeutics. 2016 Oct;13(4):895-904. doi: 10.1007/s13311-016-0448-0. Neurotherapeutics. 2016. PMID: 27324388 Free PMC article. Clinical Trial.
Sequence of Structural and Magnetic Phase Transitions in (NO)Mn6(NO3)13.
Vorobyova AA, Morozov IV, Vasilchikova TM, Zakharov KV, Ovchenkov YA, Chistyakov GD, Ivanova AG, Shvanskaya LV, Lyssenko KA, Pchelkina Z, Vasiliev AN, Volkova OS. Vorobyova AA, et al. Among authors: zakharov kv. Inorg Chem. 2024 Mar 18;63(11):5199-5207. doi: 10.1021/acs.inorgchem.4c00180. Epub 2024 Mar 6. Inorg Chem. 2024. PMID: 38447157
Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine.
Rabdano S, Ruzanova E, Makarov D, Vertyachikh A, Teplykh V, Rudakov G, Pletyukhina I, Saveliev N, Zakharov K, Alpenidze D, Vasilyuk V, Arakelov S, Skvortsova V. Rabdano S, et al. Among authors: zakharov k. Vaccines (Basel). 2024 Jan 19;12(1):100. doi: 10.3390/vaccines12010100. Vaccines (Basel). 2024. PMID: 38276672 Free PMC article.
40 results